Author: Minichart

us corporate news

Infinity Natural Resources Announces $500 Million Senior Notes Offering to Repay Debt and Fund Growth

Minichart

March 17, 2026

Infinity Natural Resources Announces \$500 Million Senior No...

Continue Reading 0

us corporate news

CNBX Pharmaceuticals Executes $45,000 Non-Convertible Promissory Note with 3i L.P. – SEC 8-K Filing March 2026 7

Minichart

March 17, 2026

CNBX Pharmaceuticals Inc. Enters into \$45,000 Non-Convertib...

Continue Reading 0

us corporate news

Quantum Cyber Aligns With Trump Administration’s National Cybersecurity Strategy, Targets Acquisitions in Quantum and Cyber Defense Sectors 1

Minichart

March 17, 2026

Quantum Cyber Aligns with National Cybersecurity Strategy an...

Continue Reading 0

us corporate news

Advantage Solutions Inc. Files Form 8-K Reporting Reverse Stock Split Process and Nasdaq Listing Status

Minichart

March 17, 2026

Advantage Solutions Inc. Announces 1-for-25 Reverse Stock Sp...

Continue Reading 0

us corporate news

Longevity Health Holdings Appoints Ram Ajjarapu as Chairman & CEO, Closes Strategic Investment to Accelerate Acquisition Growth

Minichart

March 17, 2026

Longevity Health Holdings Announces Strategic Investment and...

Continue Reading 0

us corporate news

Tianci International, Inc. Announces 1-for-7 Reverse Stock Split to Regain Nasdaq Compliance Effective March 20, 2026

Minichart

March 17, 2026

Tianci International, Inc. Announces 1-for-7 Reverse Stock S...

Continue Reading 0

us corporate news

Precision BioSciences Announces PBGENE-DMD Investor Update and Highlights ARCUS Gene Editing Platform – March 2026

Minichart

March 17, 2026

Precision BioSciences Announces Key Opinion Leader Event and...

Continue Reading 0

us corporate news

Bakkt 2025 Financial Results & Strategic Transformation: Rebuilding for the Future of Digital Assets and Financial Infrastructure

Minichart

March 17, 2026

Bakkt Holdings, Inc. Releases Full Year 2025 Financial Resul...

Continue Reading 0

us corporate news

Aldeyra Therapeutics Receives FDA Complete Response Letter for Reproxalap Dry Eye Disease Treatment, No Additional Trials Required 1

Minichart

March 17, 2026

Aldeyra Therapeutics Receives FDA Complete Response Letter f...

Continue Reading 0

us corporate news

Cencora Announces CFO Transition as James F. Cleary Retires; Reaffirms 2026 Financial Guidance

Minichart

March 17, 2026

Cencora Announces CFO Retirement and Financial Outlook Reaff...

Continue Reading 0